AKT1 and cancer: The modified compounds demonstrated significantly stronger effects in tests, including enhanced hypoglycemic effects (via the AMPK/PI3K/Akt pathways), lipid-lowering capabilities, anti-inflammatory actions, and cytotoxicity against cancer cells compared to natural berberine.